Evaluation of exoenzyme profiles of Candida albicans species isolated from females with vaginal candidiasis

Document Type : Short Communication

Authors

1 Department of Parasitology and Mycology, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

2 Research Center for Psychiatry and Behavior Science, Department of Psychiatry, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

3 Department of Radiology, School of Medicine, Medical Imaging Research Center, Shiraz University of Medical Sciences, Shiraz, Iran

4 Basic Sciences in Infectious Diseases Research Center, School of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

Abstract

Background and Purpose: The three most common causes of vaginitis are bacteria, yeast, and Protozoa. Candida albicans is one of the most common causes of vaginitis and commonly affects millions of females with different signs and symptoms. Secretion of exoenzymes from Candida species plays an important role in virulence and pathogenesis. Increasing our knowledge about the pathogenesis of candidiasis could help to design new anti-Candida drugs. This study aimed to evaluate the phospholipase, esterase, and hemolysin activities of the vaginal Candida isolates and their correlation with the presence of vulvovaginal candidiasis.
Materials and Methods: In total, 119 Candida albicans isolates from vaginal candidiasis were enrolled in the study. Egg yolk agar, Tween 80 opacity medium, and blood agar plate assays were used for the determination of phospholipase, esterase, and hemolytic activities, respectively.
Results: Based on the findings, 110 (92.44%) isolates showed phospholipase activity, 93 (78.2%) isolates were esterase producers, and 90 (75.6%) species had hemolytic activity.
Conclusion: This study showed that most of the tested isolates had different enzymatic patterns. Discrimination of variations in the production of these exoenzymes among different Candida isolates may depend on Candida spp. pathogenicity and could be responsible for the severity of symptoms among the patients.  

Keywords

Main Subjects


Introduction

Female genital tract infections have an important effect on public health and have a high incidence rate among different age groups of females. Among these infections, vaginitis refers to inflammation of the vulva and/or vagina and is caused by different groups of pathogens, such as parasites (Trichomonas), bacteria (Lactobacillus), and fungi (Candida), and has different diagnostic criteria [ 1 ]. Trichomoniasis is a common parasitic sexually-transmitted infection that may have no symptoms in 64-90% of infected people, but symptomatic females have a greatly increased volume of vaginal discharge that may be green or yellow in color, frothy, and malodorous. Bacterial vaginosis is more common in black females, smokers, intravaginal product users, and sexually active females [ 2 ].

Vulvovaginal candidiasis (VVC) is a common clinical condition with symptoms and signs, such as itching, curd-like vaginal discharge, and erythema. It is the result of overgrowth and penetration of Candida species in the vaginal mucosa and induction of an inflammatory response [ 3 ]. Candida species are the part of normal flora of the vagina and about 70-75% of women experience VVC at least once in their lifetime while approximately 50% of females experience it multiple times [ 4 ]. In general, Candida species is now ranked as the primary cause of vaginal infections. Although different species of Candida, such as C. glabrata, C. parapsilosis, and C. tropicalis cause VVC, most often it is caused by C. albicans. Over 85-90% of the vaginal Candida isolates obtained from patients with VVC are C. albicans [ 5 ].

Many risk factors are relative to the increasing rate of VVC in females, such as hormonal fluctuation, like increased estrogen levels that occur during pregnancy and menstrual cycles, diabetes, immunologic alterations, sexual activity, increased vaginal glycogen production mechanism, sustained antibiotic use, and oral contraceptive consumption [ 6 ]. Candida albicans has a lot of virulence factors that contribute to pathogenesis, including the production of adhesion to host cells, biofilm formation, phenotypic switching, and the secretion of various exoenzymes, such as phospholipases, esterase, proteases, and hemolysin [ 7 ]. Phospholipases digest the host cell membranes for better attachment, invasion, infection development, and cell destruction [ 8 ].

The ability to obtain iron in mammalian hosts by pathogenic organisms plays an important role in causing infection by them, and since in humans, most of the iron is stored inside cells as ferritin or compounds with heme, the pathogens must use hemolysin-produce mechanism to obtain iron, especially during menstruation period; hence, this enzyme is very important for organism [ 8 ].

Esterase is another hydrolyzing enzyme that breaks down ester during a chemical reaction to acid and alcohol and it is important in the pathogenicity of Candida spp. [ 9 ]. The most cases of Candida vaginitis are caused by C. albicans species. Also, the presence of high enzymatic activity may be involved in severity of invasion and destroying host cells. All these could cause exacerbating different clinical sign and symptoms. This study aimed to provide a comparative analysis of phospholipase, esterase, and hemolysin activity among the Candida albicans vaginitis isolates in patients suffering from Candida vaginitis.

Materials and Methods

Yeast isolates

In this study, in total, 119 stocks of C. albicans species that were previously recovered from Candida vaginitis patients were examined [ 10 , 11 ]. They were identified to the species level by molecular method (polymerase chain reaction-restriction fragment length polymorphism) previously and kept at -20 °C. These isolates were sub-cultured on Sabouraud dextrose agar (Merck, Germany) before usage.

Phospholipase activity

The plate method was used for the evaluation of phospholipase activity according to Price et al. [ 12 ]. The medium was prepared by the addition of 58.4 g of NaCl and 5.5 g of CaCl2 to Sabouraud dextrose agar (Merck, Germany). The sterile egg yolk was centrifuged at 5,000 ×g for 30 min and 20 mL of supernatant was added to the cooled above-mentioned medium. The inocula was prepared (2 McFarland turbidity) and 10 μL yeast suspension was spot-inoculated on the plate medium and incubated at 37 °C for up to 5 days. A precipitate zone around the colonies was measured, and expressed as Pz value from 1 to 4 as follows: Pz 1 (negative), Pz 1+ (0.9–1), Pz 2+ (0.80–0.89), Pz 3+ (0.70–0.79), and Pz 4+ (≥0.69). The standard strain of C. albicans (ATCC10261) was used as a control.

Esterase activity

Esterase activity was measured using the Tween 80 opacity test medium [ 13 ]. Moreover, 10 g of bactopepton, 5 g of NaCl, 0.1 g of Cacl2, 15g of agar, and 1,000 mL of distilled water were used for the preparation of the medium. After autoclaving, 5 ml of autoclaved Tween 80 was added to the medium and distributed in sterile 10 cm plates. Subsequently, 10 μL of Candida suspension (106 cells/ml) was inoculated as a spot on the plates and kept at 35 ° C for 10 days. The colony diameter (a) and the diameter of the colony plus precipitation zone (b) were measured to calculate the zone of esterase activity.

Hemolysin activity

Blood plate assay was used as explained by Yigit and Aktas for hemolytic activity [ 14 ]. By the addition of 7% v/v of fresh sheep blood and 3% w/v of glucose to Sabouraud dextrose agar, the media was prepared. Afterward, 2 McFarland turbidity of yeast samples suspension was prepared and 10 μL was spotted on medium and incubated at 37 °C for 48 h. For hemolytic activity, a ring of lysis around the colonies was considered complete: in case of a totally translucent ring; beta, incomplete: in case of a greenish-black halo; alpha, and no hemolysis: gamma or none. Candida albicans ATCC10261 was used as a control.

Statistical Analysis

Results were analyzed in the SPSS software (version 22).

Ethical approval

This project was in accordance with the ethical principles and the national norms and standards for the conduction of Medical Research in Iran and has been approved by the Research Ethics Committee of Shiraz University of Medical Sciences, Shiraz, Iran (IR. SUMS.REC.1390.3755).

Results and Discussion

Vulvovaginal candidiasis corresponds to an infection that is the second cause of vaginitis and leads females to frequent medical visits in different parts of the world. Due to the development of gynecological examinations, many females present with VVC which is associated with horrible and painful signs and symptoms for most patients. Candida species are a normal commensal in the human body, including the female genital tract. Abnormal growth of yeasts in the region of the female genital tract causes VVC [ 15 ]. Its growth is controlled and limited by the immune system and the dynamics of complex bacterial microbiome.

Candida albicans is responsible for the majority of symptomatic VVC. Many factors have been attributed to the pathogenic potentials of C. albicans, such as the secretion of various enzymes, phenotypic switching, biofilm formation, and yeast-to-hypha transition. According to previous studies, C. albicans isolates could secrete higher amounts of these enzymes, compared to non-albicans Candida, and the ability of exo-enzyme production was an important virulence factor in C. albicans isolates [ 8 , 16 ]. Ability of this organism to produce extracellular enzymes may play a role in its pathogenicity, invasion, and destruction of host tissues and also could create and develop clinical signs.

In addition, there is a significant statistical correlation between enzymatic production and resistance of yeasts to azole antifungal agents [ 18 ]. Candida albicans use their phospholipase and hemolysin enzyme activity to invade to host tissue. Furthermore, the esterase enzyme, as a hydrolyzing enzyme, plays an important role in Candida invasion by breaking down fats. Although Candida has the ability to produce these enzymes, their amount and strength vary among the different species, which may be due to the source of their isolation [ 18 , 19 ]. Phospholipase secretions also help the organism to escape from host defense mechanisms [ 8 ].

In this study, analysis of Egg yolk agar test data showed that most of the samples had phospholipase activity in different ranges (Figure 1). In total, 110 (92.44%) out of 119 samples had phospholipase activity, 98 species (82.3%) showed +4 positive for phospholipase activity, and only 9 isolates (7.56%) had no phospholipase activity. More details are summarized in Table 1.

Figure 1. Esterase and Phospholipase production of Candida albicans isolates. A) No esterase production was observed. B) Positive activity of esterase was observed. C) No phospholipase production was observed. D) Dense white zone of precipitation around the colony indicated phospholipase activity.

Exoenzyme Activity
Negative 1+ 2+ 3+ 4+
Esterase activity Number (%) 26 (21.8) 0(0) 1(0.84) 4(3.3) 88(73.9)
Phospholipase activity Number (%) 9 (7.56) 0(0) 4(3.36) 8(6.7) 98(82.3)
Table 1.Frequency of phospholipase activity and esterase activity in different isolates of Candida albicans

In a study performed by Sachin et al. [ 20 ], 92.3% of C. albicans isolates demonstrated phospholipase activity, but in another study conducted by Shirkhani et al. [ 21 ], only 29.4% of C. albicans isolates had phospholipase activity. Therefore, the amount of this secretion could be important in tissue invasion for organisms and could aggravate clinical symptoms in infected people.

Hemolytic enzymes are another important factor in the pathogenicity of Candida that enable the pathogen to extract iron from hemoglobin or hemin molecules in host cells [ 22 ]. Due to the vaginal environment covers with large amounts of blood during menstruation, this condition can further activate this enzyme in Candida species and provide iron from the blood. In the present study, 75.6%, 67.2% (80), 8.4% (10), and 24.4% (29) of isolates had hemolytic activity, beta-hemolytic activity, alpha-hemolytic activity, and gamma hemolytic activity with no hemolytic activity, respectively.

In a study carried out by Sachin et al. [ 20 ], hemolytic activity was detected in 100% and 94.8% of samples of C. albicans, respectively; however, these data were not in line with those of the present study. Esterase activity is another virulence factor in C. albicans which contributes to host tissue invasion by disruption of host cell membranes [ 9 ]. In the present study, the evaluation of data from the Tween 80 opacity test demonstrated that 93 (78.2%) out of 119 studied samples had esterase activity (Figure 1), and 88 isolates (73.9%) showed +4 positive esterase activity. Moreover, 26 isolates (21.8%) had no esterase activity (Table 1). It should be noted that these virulence factors play a crucial role in the pathogenesis. Detection of virulence factors, like phospholipase, esterase, and hemolysin activity will help provide sufficient data for a better understanding of the relationship between infection and the isolated Candida species. Besides, the severity of extracellular enzymes may play a role in the severity of signs and symptoms of vulvovaginal candidiasis. Knowledge about these virulence factors can be used to improve disease management and treatment. However, further studies in a higher number of species are required to confirm these findings.

Conclusion

Vulvovaginitis is considered a complex infection that occurs due to different microorganisms in the vagina. Candida albicans is one of the most common reasons for vaginitis. Virulence factors, like phospholipase, esterase, and hemolysin activity, play important roles in the pathogenicity of C. albicans. These findings should help the effective administration of Candida vaginitis. Continued observation would greatly support the management of this largely opportunistic infection. Further research aimed at the characterization of possible risk factors as well as preventive therapy and treatment is suggested.

Acknowledgments

This study was funded by the Research and Technology Deputy of Shiraz University of Medical Sciences, Shiraz, Iran. This study was derived from a thesis submitted by Leila Razeghian Jahromi in partial fulfillment of the requirement for the degree of MD to Shiraz University of Medical Sciences.

Author’s contribution

H. N.: Manuscript writing/editing. L. R. J.: Data collection. M. GH. J.: Data collection. K. Z.: Data analysis. K. P.: Manuscript writing/editing and project development. All authors read and approved the final manuscript.

Conflicts of interest

The authors report no conflicts of interest.

Financial disclosure

No financial interests related to the material of this manuscript have been declared. This study was funded by the Deputy of Research and Technology of Shiraz University of Medical Sciences, Shiraz, Iran, Grant No 3755.

References

  1. Rigo GV, Tasca T. Vaginitis: Review on Drug Resistance. Curr Drug Targets. 2020; 21(16):1672-86.
  2. Brown JM, Hess KL, Brown S, Murphy C, Waldman AL, Hezareh M. Intravaginal practices and risk of bacterial vaginosis and candidiasis infection among a cohort of women in the United States. Obstet Gynecol. 2013; 121(4):773-780.
  3. Pakshir K, Sheykhi S, Zomorodian K, Nouraei H, Zare Shahrabadi Z. Evaluation of biofilm formation in the homozygous and heterozygous strains of vaginal Candida albicans isolates. Curr Med Mycol. 2019; 5(2):37-40.
  4. Gonçalves B, Ferreira C, Alves CT, Henriques M, Azeredo J, Silva S. Vulvovaginal candidiasis: Epidemiology, microbiology and risk factors. Crit Rev Microbiol. 2016; 42(6):905-27.
  5. Kalia N, Singh J, Kaur M. Microbiota in vaginal health and pathogenesis of recurrent vulvovaginal infections: a critical review. Ann Clin Microbiol Antimicrob. 2020; 19(1):5.
  6. Reed BD, Zazove P, Pierson CL, Gorenflo DW, Horrocks J. Candida transmission and sexual behaviors as risks for a repeat episode of Candida vulvovaginitis. J Womens Health (Larchmt).. 2003; 12(10):979-89.
  7. Nouraei H, Sheykhi S, ZareShahrabadi Z, Khodadadi H, Zomorodian K, Pakshir K. Comparative Analysis of Virulence Factors of Homozygous and Heterozygous Strains of Candida albicans Vaginal Isolates. Int J Microbiol. 2020; 2020:8889224.
  8. Nouraei H, Pakshir K, ZareShahrabadi Z, Zomorodian K. High detection of virulence factors by Candida species isolated from bloodstream of patients with candidemia. Microb Pathog. 2020; 149:104574.
  9. Pakshir K, Zomorodian K, Karamitalab M, Jafari M, Taraz H, Ebrahimi H. Phospholipase, esterase and hemolytic activities of Candida spp. isolated from onychomycosis and oral lichen planus lesions. J Mycol Med. 2013; 23(2):113-8.
  10. Akbarzadeh M, Bonyadpoure B, Pacshir K, Mohagheghzadeh A. Causes and clinical symptoms of vaginal candidiasis in patients referring to selective clinics of Shiraz University of Medical Sciences (2009). J Arak Uni Med Sci. 2010; 13 (3): 12-20.
  11. Mousavi MS, Keshavarz T, Montaseri H, Pakshir K, Yazdani M, Zare N, Afrouzan H. A comparative study on the therapeutic effect of the propolis vaginal cream and clotrimazole on Candida vulvovaginitis in reproductive aged women. Journal of Isfahan Medical School. 2011; 28(117):1099-107.
  12. Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia. 1982 Mar; 20(1):7-14.
  13. Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microbiol. 2000; 38(12):4626-8.
  14. Yigit N, Aktas E. Comparison of the efficacy of different blood medium in determining the hemolytic activity of Candida species. Journal de Mycologie MÚdicale. 2009 ; 19(2):110-5.
  15. Álvares CA, Svidzinski TI, Consolaro ME. Vulvovaginal candidiasis: susceptibility factors of the host and virulence of the yeasts. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2007; 43:319-27.
  16. Fathi F, Zarei Mahmoudabadi A, Fatahinia M. A comparative study on the production of extracellular hydrolytic enzymes of C. albicans and non-albicans Candida species isolated from HIV+/AIDS patients and healthy individuals. Curr Med Mycol. 2022; 8(2):32-39.
  17. Farhan MA, AM AM, Salah T, Shaaban OM. Relationship between antifungal resistance and enzymatic activities of yeasts causing oral and vaginal mycosis. Assuit University Journal of Botany and Microbiology. 2019; 48(1):1-6.
  18. Sriphannam C, Nuanmuang N, Saengsawang K, Amornthi-payawong D, Kummasook A. Anti-fungal susceptibility and virulence factors of Candida spp. isolated from blood cultures. J Mycol Med. 2019; 29(4):325-330.
  19. Aparna T, Raphy HM, KS HK, Innu S. Phospholipase, proteinase, esterase and haemolytic activity of Candida species isolated from oral cavity and its antifungal susceptibility pattern. International Journal of Research in Medical Sciences. 2023; 11(7):2476.
  20. Sachin CD, Ruchi K, Santosh S. In vitro evaluation of proteinase, phospholipase and haemolysin activities of Candida species isolated from clinical specimens. International journal of Medicine and Biomedical research. 2012; 1(2):153-7.
  21. Shirkhani S, Sepahvand A, Mirzaee M, Anbari K. Phospholipase and proteinase activities of Candida spp. isolates from vulvovaginitis in Iran. J Mycol Med. 2016; 26(3):255-60.
  22. Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol. 2001; 39(8):2971-4.
Volume 9, Issue 4
December 2023
Pages 51-54
  • Receive Date: 30 August 2023
  • Revise Date: 09 January 2024
  • Accept Date: 09 January 2024
  • First Publish Date: 09 January 2024